期刊文献+

天舒胶囊合苯磺酸氨氯地平对高血压患者生活质量影响的临床观察 被引量:5

Clinical Effect of Tianshu Capsule and Levamlodipine Besylate Tablets on Patients with Hypertension of Blood Stasis
下载PDF
导出
摘要 目的研究天舒胶囊合苯磺酸氨氯地平对高血压患者生活质量的影响。方法采用单盲平行对照和患者自身前后对照的研究方法。治疗组服用苯磺酸氨氯地平合天舒胶囊。对照组服用苯磺酸氨氯地平。比较治疗前后2组患者生活质量、血压值的变化,评价天舒胶囊对高血压病患者生活质量改善的情况。结果治疗前,治疗组和对照组比较,生活质量积分、血压水平无明显差异(P>0.05)。经治疗后,治疗组的生活质量积分、与对照组有明显差异(P<0.05);而治疗组和对照组的血压下降水平在治疗后组内比较有显著差异,组间比较无明显差异(P>0.05)。结论天舒胶囊联合苯磺酸氨氯地平治疗高血压具有提高患者生活质量的作用。 Objective To investigate the clinical effect of Tianshu capsule on the quality of life(QOL) of patients with hypertension.Methods A total of 60 patients with hypertension were randomely divided into 2 groups,the treated group and control group.All the patients were treated with levamlodipine besylate tablets,while patients in the treated group also treated with Tianshu capsule.The total scores of QOL and the blood pressure of patients before and after the treatment were compared.Results The quality of life and the blood pressure of patients had no obvious difference between the treatment group and control group before the treatment(P0.05).After the treatment,the quality of life of patients in the treatment group had significant differentce compared with those of control group(P0.05).But the blood pressure did not have obvious difference between treatment group and control group after the treatment(P0.05).Conclusion Tianshu capsule combined with levamlodipine besylate tablet is effective in improving patient's quality of life.
作者 梁迪赛 袁丁
出处 《今日药学》 CAS 2011年第7期452-453,456,共3页 Pharmacy Today
关键词 天舒胶囊 苯磺酸氨氯地平 高血压 生活质量 Tianshu capsule levamlodipine besylate tablets hypertension quality of life
  • 相关文献

参考文献8

二级参考文献50

  • 1陈道揆,宋振才.高血压病患者左室肥厚的超声心动图测量与心电图标准的对比研究[J].中国超声医学杂志,1995,11(1):67-68. 被引量:7
  • 2尹学亮,李建柱,梁添书,张启确,曾文坦.辛伐他汀对原发性高血压患者血、尿β_2-微球蛋白的影响[J].临床内科杂志,2007,24(1):52-53. 被引量:9
  • 3李翠玲,崔正言,李淑贞.MTT比色分析法的改良及初步应用[J].上海免疫学杂志,1996,16(5):306-307. 被引量:59
  • 4鄢盛恺,周新,哈黛文.聚合酶链反应限制性片段长度多态性检测载脂蛋白E基因型[J].中华医学检验杂志,1997,20(1):28-31. 被引量:60
  • 5王宁生.关于血清药理学的若干思考[J].中国中西医结合杂志,1999,19(5):263-263.
  • 6Wang SL,Head J,Stevens L,et al. The world health organization multinational study group:excess mortality and it's relation to hypertension and proteinuria in diabetic patients. The world health organization multinational study of vascular disease in diabetes [ J ]. Diabetes Care, 1996,19(4) :305 -312.
  • 7Mogensen CE, Keane Bennett PH, et al. Prevention of diabetic renal disease with special reference to microal baminuria[J]. Lancet, 1995, 346 (8982) : 1080 - 1084.
  • 8Branten AJ,du Bur Vereijken PW, Klasen IS, et al. Urinary excretion of beta2-microglobulin and IgG prognosis in Idiopathic membranous nephropathy: a validation study[ J]. J Am Soc Nephrol,2005,16 ( 1 ) : 169 - 174.
  • 9Iino Y, Hayashi M, Kawamura T,et al. Renoprotective effect of losartan in comparison to amlodipine in patients with chronic kidney disease and hypertensiana report of the Japanese losartan therapy intended for the global renal protection in hypertensive patients( JL IGHT) study[ J]. Hypertens Res ,2004,27 ( 1 ) :21 - 30.
  • 10[1]Pasquier F, Henon H, Leys D. Relevance of white matter changes to pre- and poststroke dementia[J]. Ann N Y Acad Sci, 2000, 903(4): 466-469.

共引文献38

同被引文献151

引证文献5

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部